-The Times of India NEW DELHI: If the dictum 'you can't manage what you can't measure' is true, then the government has an unsure grip over at least half the 13 flagship schemes worth nearly Rs 2 lakh crore annually, almost 80% of the total spend on central schemes. The government is unable to efficiently collate information to assess whether some of the 13 key flagship schemes are producing the results for...
More »SEARCH RESULT
Total Matching Records found : 3404
Government regularizes 40,000 more pensioners -Ambika Pandit
-The Times of India NEW DELHI: The Delhi cabinet on Monday "formally approved" the inclusion of 40,000 additional beneficiaries in the old age pension scheme. The approval amounts to regularization of pensioners registered and in receiving financial assistance, even though they exist beyond the cap of 3.5 lakh permitted under the scheme of the social welfare department. The easing of the cap is to tide over a legal crisis and a face-saving exercise...
More »PF set to cover all pay, not jut basic pay -Sidhartha
-The Economic Times NEW DELHI: You may end up saving more in the months ahead with the Employees Provident Fund Organization (EPFO) readying to re-notify a new definition of "compensation" that will include all your allowances, amid intense lobbying against the move by industry bodies. Currently, employers get away by contributing only 12% of the basic salary and dearness allowance, which is not paid by most companies, towards their share of "matching"...
More »Deafness in Tamil Nadu 3 times higher than national average
-The Times of India CHENNAI: Hearing impairment being the most common congenital anomaly in newborns, the rising numbers indicate that the state would soon become the deafness capital of the country if efforts are not taken at the earliest to curb it, warn experts. A study conducted by a medical team of the Madras ENT Research Foundation (MERF) found that six out of every 1,000 kids were victims of severe to profound...
More »A deception most foul-Narayan Lakshman
-The Hindu Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...
More »
